These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18262771)

  • 1. Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study.
    Saddichha S; Manjunatha N; Ameen S; Akhtar S
    Schizophr Res; 2008 Apr; 101(1-3):266-72. PubMed ID: 18262771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study.
    Saddichha S; Manjunatha N; Ameen S; Akhtar S
    J Clin Psychiatry; 2007 Nov; 68(11):1793-8. PubMed ID: 18052574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and aerobic fitness in patients with first-episode schizophrenia, including a 1-year follow-up.
    Nyboe L; Vestergaard CH; Moeller MK; Lund H; Videbech P
    Schizophr Res; 2015 Oct; 168(1-2):381-7. PubMed ID: 26278336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review.
    De Hert M; Schreurs V; Sweers K; Van Eyck D; Hanssens L; Sinko S; Wampers M; Scheen A; Peuskens J; van Winkel R
    Schizophr Res; 2008 Apr; 101(1-3):295-303. PubMed ID: 18299188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.
    Meyer JM; Davis VG; Goff DC; McEvoy JP; Nasrallah HA; Davis SM; Rosenheck RA; Daumit GL; Hsiao J; Swartz MS; Stroup TS; Lieberman JA
    Schizophr Res; 2008 Apr; 101(1-3):273-86. PubMed ID: 18258416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.
    Fleischhacker WW; Siu CO; Bodén R; Pappadopulos E; Karayal ON; Kahn RS;
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):987-95. PubMed ID: 23253821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia.
    Marthoenis M; Aichberger MC; Puteh I; Syahrial S; Schouler-Ocak M
    Asian J Psychiatr; 2015 Jun; 15():10-4. PubMed ID: 25910596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up.
    Medved V; Kuzman MR; Jovanovic N; Grubisin J; Kuzman T
    J Psychopharmacol; 2009 Nov; 23(8):915-22. PubMed ID: 18635691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
    Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
    Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.
    De Hert MA; van Winkel R; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    Schizophr Res; 2006 Mar; 83(1):87-93. PubMed ID: 16481149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
    Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
    Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
    Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
    J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
    Pallava A; Chadda RK; Sood M; Lakshmy R
    Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study.
    Bobes J; Arango C; Aranda P; Carmena R; Garcia-Garcia M; Rejas J;
    Schizophr Res; 2007 Feb; 90(1-3):162-73. PubMed ID: 17123783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and schizophrenia - effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia.
    Saddichha S; Manjunatha N; Ameen S; Akhtar S
    Acta Psychiatr Scand; 2008 May; 117(5):342-7. PubMed ID: 18307585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of electroacupuncture on metabolic syndrome due to olanzapine and risperidone: Study protocol for a randomized controlled pilot trial.
    Ning Y; Jia H; Chen P; Zhu H; Yin D
    Medicine (Baltimore); 2019 Sep; 98(38):e17237. PubMed ID: 31567988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population.
    Lee NY; Kim SH; Cho B; Lee YJ; Chang JS; Kang UG; Kim YS; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1243-9. PubMed ID: 20599461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.